Electromed Inc
Research Electromed Inc (ELMD) on Bullrun: valuation model: 2.2% overvalued, market cap USD 325.74M, P/E 33.8. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerELMD
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal2.2% overvalued
- Market capUSD 325.74M
- P/E33.8
- Financial periodQ1 2026
- RevenueUSD 18.58M
- Net incomeUSD 3.00M
- Free cash flowUSD 3.32M
- Gross margin78.8%
Valuation Snapshot
Bullrun's latest valuation model marks Electromed Inc as 2.2% overvalued; latest market cap is USD 325.74M; P/E is 33.8.
Peer valuation comparison
Latest P/E is 33.8x versus a Healthcare sector median of 24.46x (38.2% above).
Latest P/E is 33.8x versus a United States median of 24.87x (35.9% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 64.00M | USD 7.54M | USD 11.13M | 78.1% | 0.85 | USD 15.29M | n/a | USD 43.21M |
| FY2024 | USD 54.72M | USD 5.15M | USD 8.78M | 76.3% | 0.58 | USD 16.08M | n/a | USD 44.55M |
| FY2023 | USD 48.07M | USD 3.17M | -USD 333.00K | 76.0% | 0.36 | USD 7.37M | n/a | USD 37.67M |
| FY2022 | USD 41.66M | USD 2.31M | -USD 2.11M | 75.5% | 0.26 | USD 8.15M | n/a | USD 34.17M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 325.74M | 33.8 | n/a | n/a |
| 2025 | 2025-12-31 | USD 241.10M | 28.3 | n/a | n/a |
| 2024 | 2024-12-31 | USD 252.85M | 38.9 | n/a | n/a |
| 2023 | 2023-12-29 | USD 93.63M | 29.5 | n/a | n/a |
| 2022 | 2022-12-30 | USD 89.01M | 47.7 | n/a | n/a |
| 2021 | 2021-12-31 | USD 110.93M | 59.1 | n/a | n/a |
About Electromed Inc
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Electromed Inc overvalued or undervalued?
Bullrun's valuation model currently marks Electromed Inc as 2.2% overvalued.
What is Electromed Inc's market cap?
Electromed Inc's market capitalization is USD 325.74M.
What is Electromed Inc's P/E ratio?
Electromed Inc's price-to-earnings (P/E) ratio is 33.8.
What does Electromed Inc do?
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.